Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by Hermes8on Jun 08, 2011 9:58am
363 Views
Post# 18686037

Highlights from 2010 & 2011W drill programs

Highlights from 2010 & 2011W drill programsBrewery Creek - Drilling ongoing through Q1-2012 (Yukon)

• 2011 winter drilling reported significant mineralization on 24 of the 25 holes drilled:
• Hole BC11-198 74.0 m of 7.08 g/t Au including 57.5 m of 8.90 g/t Au
• Hole BC11-199 51.6 m of 1.71 g/t Au including 41.1 m of 2.02 g/t Au
• Hole BC11-176 32.9 m of 3.01 g/t Au
• New higher-grade discoveries at Bohemian and Schooner Zones; deposit is open to the east

Bohemian Zone Brewery Creek Project, Select Significant Intercepts
> Drill Hole BC10-168 50.5 m of 2.79 g/t Au including 21.5 m of 5.35 g/t Au
> Drill Hole BC10-170 56.5 m of 3.20 g/t Au
> Drill Hole BC10-171 27.5 m of 1.15 g/t Au
> Drill Hole BCRC10-2322 38.1 m of 1.48 g/t Au
2010 Results Press Release on September 10, 2010 and December 10, 2010


Grew Creek - Drilling ongoing through Q4-2011 (Yukon)

Drilling commenced February 2011 –results pending
Winter 2011 Drill Program - Best result from Carlos Zone: Eight holes have intersected significant mineralization, including 98.3 m of 1.83 g/t gold beginning at a depth of 54.9 m in core hole GC11-271.

• 3 holes drilled in 2010, all intersected significant mineralization:
146.3 m of 1.72 g/t Au from hole GC10-001
132.18 m of 1.21 g/t Au and 31.75 m of 2.08 g/t Au from hole GC10-002
(bottomed in mineralization)
60.85 m of 1.93 g/t Au and 8.5 m of 1.89 g/t Au from hole GC10-003

Clear Creek Project - Drilling commencing in Q2-2011 and will continue through Q3-2011 (Yukon)

Major 42 hole RC & core drill program completed August 2010:
- 25.91 m of 2.59 g/t Au including 9.15 m of 5.64 g/t Au from RC Hole CC10-07(4)
- 22.86 m of 1.24 g/t Au from 10.67 m depth from RC Hole CC10-25(5)
- 1.52 m of 137.50 g/t Au from 3.05 m depth from RC Hole CC10-22(6)

Bullboard Posts